Drug Shortage Report for TEVA-CARVEDILOL
Report ID | 141107 |
Drug Identification Number | 02252309 |
Brand name | TEVA-CARVEDILOL |
Common or Proper name | CARVEDILOL 3.125MG TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | CARVEDILOL |
Strength(s) | 3.125MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | C07AG |
ATC description | BETA BLOCKING AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-06-16 |
Estimated end date | 2021-07-31 |
Actual end date | 2021-07-08 |
Shortage status | Resolved |
Updated date | 2021-07-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2021-07-09 | English | Compare |
v4 | 2021-07-08 | French | Compare |
v3 | 2021-07-08 | English | Compare |
v2 | 2021-06-17 | French | Compare |
v1 | 2021-06-17 | English | Compare |
Showing 1 to 5 of 5